Chemoinformaics analysis of ALKANNIN-BETA,BETA-DIMETHYLACRYLATE
| Molecular Weight | 370.401 | nRot | 5 |
| Heavy Atom Molecular Weight | 348.225 | nRig | 15 |
| Exact Molecular Weight | 370.142 | nRing | 2 |
| Solubility: LogS | -3.193 | nHRing | 0 |
| Solubility: LogP | 5.423 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 54.5514 |
| nHD | 2 | BPOL | 26.4106 |
| QED | 0.208 |
| Synth | 3.431 |
| Natural Product Likeliness | 1.28 |
| NR-PPAR-gamma | 0.878 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.021 |
| Pgp-sub | 0.989 |
| HIA | 0.316 |
| CACO-2 | -5.082 |
| MDCK | 0.0000249 |
| BBB | 0.004 |
| PPB | 0.989395 |
| VDSS | 0.377 |
| FU | 0.0429723 |
| CYP1A2-inh | 0.967 |
| CYP1A2-sub | 0.755 |
| CYP2c19-inh | 0.773 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.921 |
| CYP2c9-sub | 0.947 |
| CYP2d6-inh | 0.837 |
| CYP2d6-sub | 0.704 |
| CYP3a4-inh | 0.114 |
| CYP3a4-sub | 0.156 |
| CL | 2.651 |
| T12 | 0.862 |
| hERG | 0.002 |
| Ames | 0.653 |
| ROA | 0.749 |
| SkinSen | 0.959 |
| Carcinogencity | 0.161 |
| EI | 0.945 |
| Respiratory | 0.366 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.659817 |